Models of experimental hypertension in mice

Hypertension

Volumn 28, Issue 6, 1996, Pages 1064-1069

  Johns, Conrado ^a   Gavras, Irene ^a   Handy, Diane E ^a   Salomao, Abrahao ^a   Gavras, Haralambos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blood pressure monitoring; deoxycorticosterone; hypertension, mineralocorticoid; hypertension, renovascular; mice

Indexed keywords

DEOXYCORTICOSTERONE; MINERALOCORTICOID; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; EXPERIMENTAL MODEL; HEART WEIGHT; HYPERTENSION; KIDNEY MASS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; UNINEPHRECTOMY;

EID: 0029852348     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.6.1064     Document Type: Article

References (38)

1. Shuldiner AR. Transgenic animals. N Engl J Med. 1996;334: 653-655.
2. Chien KR. Genes and physiology: molecular physiology in genetically engineered animals. J Clin Invest. 1996;97:901-909.
3. Goldblatt H, Lunch J, Hanzal RF, Summerville WW. Studies on experimental hypertension, I: the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347-378.
4. Brunner HR, Kirshman JD, Sealey JE, Laragh JH. Hypertension of renal origin: evidence for two different mechanisms. Science. 1971; 174:1344-1346.
5. Gavras H, Brunner HR, Vaughan ED Jr, Laragh JH. Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science. 1973;180:1369-1372.
6. Gavras H, Brunner HR, Thurston H, Laragh JH. Reciprocation of renin dependency with sodium volume dependency in renal hypertension. Science. 1975;188:1316-1317.
7. Selye H, Hall CE, Rowley EM. Malignant hypertension produced by treatment with desoxycorticosterone acetate and sodium chloride. Can Assoc J. 1943;49:88-92.
8. Gavras H, Brunner HR, Laragh JH, Vaughan ED Jr, Koss M, Cote LJ, Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res. 1975;36:300-309.
9. Mariguchi A, Brosnihan KB, Kumagai H, Ganten D, Ferrario CM. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 1994;266(pt 2):R1273-R1279.
10. Whitworth CE, Fleming S, Cumming AD, Morton JJ, Burns NJ, Williams BC, Mullins JJ. Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int. 1994;46: 1528-1532.
11. Campbell DJ, Rong P, Kladis A, Rees B, Ganten D, Skinner SL. Angiotensin and bradykinin peptides in the TGR (mRen-2)27 rat. Hypertension. 1995;25:1014-1020.
12. Kuro-o M, Hanaoka K, Hiroi Y, Noguchi T, Fujimori Y, Takewaki S, Hayasaka M, Katoh H, Miyagishi A, Nagai R, Yazaki Y, Nabeshima O. Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger. Circ Res. 1995;76:148-153.
13. Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F, Jacob H, Fuxe K, Ganten D, Kaling M. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 1992;11:821-827.
14. Steinhelper ME, Cochrane KL, Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension. 1990;16:301-307.
15. Veress AT, Chong CK, Field LJ, Sonnenberg H. Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets. Am J Physiol. 1995;269:R186-R192.
16. Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, Nakao K. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest. 1994;93:1911-1921.
17. Ohkubo H, Kawakami H, Kakehi Y, Takumi T, Arai H, Yokota Y, Iwai M, Tanabe Y, Masu M, Hata J, Iwao H, Okamoto H, Yokoyama M, Nomura T, Katsuki M, Nakanishi S. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci U S A. 1990;87: 5153-5157.
18. Fukamizu A, Sugimura K, Takimolo E, Sugiyama F, Seo M-S,Takahashi S, Hatae T, Kajiwara N, Yagami K, Murakami K. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem. 1993;268:11617-11621.
19. Yang G, Merrill DC, Thompson MW, Robillard JE, Sigmund CD. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem. 1994;269:32497-32502.
20. Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 1994;23:236-243.
21. Lopez MJ, Wong SK-F, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A. Salt-resistant hypertension in mice lacking the guanylyl cyclase - A receptor for atrial natriuretic peptide. Nature. 1995;378:65-68.
22. Hein L, Barsh G, Pratt RE, Dzau VJ, Kobilka BK. Behavioral and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature. 1995;377:744-747.
23. Ichiki T, Labosky PA, Shiota C, Okuyana S, Imagama Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
24. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao W, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 1994;368:703-710.
25. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K. Angiotensinogen-deficient mice with hypotension. J Biol Chem. 1994;269:31334-31337.
26. Kim H, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735-2739.
27. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 1995;267:679-681.
28. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature. 1995;375:146-148.
29. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
30. Smithies O, Maeda N. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc Natl Acad Sci U S A. 1995;92:5266-5272.
31. 2-adrenergic receptor. Science. 1994;264:582-586.
32. 2C-adrenoceptor homolog. Mol Pharmacol. 1995;48:48-55.
33. Schlager G. Genetic hypertension in different strains of mice. In: de Jong W, ed. Handbook of Hypertension, Volume 4: Experimental and Genetic Models of Hypertension. New York, NY: Elsevier Science Publishers; 1984:193-199.
34. Mills E, Kuhn CM, Feingloss MN, Surwit R. Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. Am J Phjolevsiol. 1993;264(pt 2):R73-R78.
35. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension. 1995;25:1111-1115.
36. Ferrari AU, Daffonchio A, Albergati F, Bertoli P, Mancia G. Intraarterial pressure alterations during tail-cuff blood pressure measurements in normotensive and hypertensive rats. J Hypertens. 1990;8: 909-911.
37. Raij L, Dalmasso AP, Staley NA, Fish AJ. Renal injury in DOCA-sall hypertensive C5-sufficient and C5-deficient mice. Kidney Int. 1989;36:582-592.
38. Pickering G. Experimental hypertension. In: High Blood Pressure. 2nd ed. London, UK: Churchill; 1968:140-170.